Quantcast
Last updated on April 18, 2014 at 15:19 EDT

Latest Band of Parents Stories

2012-10-15 15:23:34

After leukaemia and brain tumors, neuroblastoma is the most common form of cancer to affect children. A thesis from the Sahlgrenska Academy, University of Gothenburg, Sweden, has studied a DNA method which is now used for all cases of neuroblastoma in Sweden, and which has led to more effective treatment at individual level. Neuroblastoma affects around 20 children each year, most of them under the age of two. This form of cancer, which affects the peripheral nervous system, is...

2012-09-14 15:20:21

A whole-genome scan to identify large-scale chromosomal damage can help doctors choose the best treatment option for children with neuroblastoma, one of the most common types of childhood cancer, finds an international collaboration jointly led by The Institute of Cancer Research, London. The researchers called for all children diagnosed with neuroblastoma worldwide to have a whole-genome scan as a standard part of their treatment. Neuroblastoma, a cancer of the developing nervous...

2012-07-11 14:47:35

A new drug combination could offer hope to children with neuroblastoma — one of the deadliest forms of childhood cancer — by boosting the effectiveness of a promising new gene-targeted treatment. Researchers at The Institute of Cancer Research in London have found a way to overcome the resistance of cancer cells to a drug called crizotinib, which recently showed positive early results in its first trial in children with cancer. Crizotinib has already been licensed by the US...

2012-06-21 23:01:43

On June 23, 2012, the Matthew Bittker Foundation will present the Children´s Hospital of Michigan Foundation (CHM Foundation) with a check for $50,000 to advance the research and treatment for children diagnosed and/or treated with neuroblastoma at the DMC Children´s Hospital of Michigan. Detroit, Michigan (PRWEB) June 21, 2012 On June 23, 2012, the Matthew Bittker Foundation will present the Children´s Hospital of Michigan Foundation (CHM Foundation) with a check for $50,000...

2012-06-18 02:26:22

HOUSTON, June 18, 2012 /PRNewswire-USNewswire/ -- Dr. Eugene Kim, a pediatric surgeon with Texas Children's Cancer Center and assistant professor of surgery at Baylor College of Medicine (BCM), and Dr. Jason Shohet, chair of the Neuroblastoma Research Program at Texas Children's Cancer Center and associate professor in the Section of Hematology-Oncology at BCM, will speak at the Advances in Neuroblastoma Research (ANR) conference about the identification of a novel stem cell population in...

2012-03-14 11:49:00

St. Jude Children's Research Hospital — Washington University Pediatric Cancer Genome Project and Memorial Sloan-Kettering Cancer Center discover first gene alteration associated with patient age and neuroblastoma outcome Researchers have identified the first gene mutation associated with a chronic and often fatal form of neuroblastoma that typically strikes adolescents and young adults. The finding provides the first clue about the genetic basis of the long-recognized but poorly...

2012-03-13 15:00:00

MEMPHIS, Tenn., March 13, 2012 /PRNewswire/ -- Researchers have identified the first gene mutation associated with a chronic and often fatal form of neuroblastoma that typically strikes adolescents and young adults. The finding provides the first clue about the genetic basis of the long-recognized but poorly understood link between treatment outcome and age at diagnosis. To view the multimedia assets associated with this release, please click:...

2011-10-19 19:15:59

Two Baylor College of Medicine physicians have received support from the nonprofit group Cookies for Kids' Cancer for their research on neuroblastoma — a common type of solid tumor in children. Dr. Leonid Metelitsa, associate professor of pediatrics at BCM and a pediatric oncologist at Texas Children's Cancer Center, and Dr. Jed Nuchtern, professor of pediatrics and of surgery at BCM, who is a surgical oncologist at the center, each received $100,000 from the organization. The...

2011-09-19 23:49:08

Poorer treatment outcomes Patients with a high degree of African ancestry had a greater incidence of high-risk neuroblastoma and poorer outcomes, according to preliminary results presented here at the Fourth AACR Conference on The Science of Cancer Health Disparities, held here Sept. 18-21, 2011. "There are common genetic variants that are associated with the development of high-risk neuroblastoma and a poor outcome," said Navin R. Pinto, M.D., instructor of pediatrics at the University...

2010-11-29 07:56:13

(Ivanhoe Newswire) -- Neuroblastoma is the most common extracranial solid cancer in childhood and the most common cancer in infancy, with an annual incidence of about 650 new cases per year in the United States.  Close to 50 percent of neuroblastoma cases occur in children younger than two years old.  A recent study has revealed that African American, Asian, and Native American children are more likely than Caucasian and Hispanic children to die after being treated for...